Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment
Ontology highlight
ABSTRACT: The specific aims of this study are as follows:
1. Primary endpoint: to evaluate the clinical responses of vaccinated patients.
2. Secondary endpoint: to evaluate the safety of this treatment and the immune responses against CEA before and after the treatment
DISEASE(S): Colorectal Cancer,Colorectal Neoplasms
PROVIDER: 2016110 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA